
|Articles|March 2, 2015
Majority of Metaplastic Breast Cancers May Be Targetable
Author(s)Sherri Z. Millis, PhD
In this video from MBCC we discuss a poster presentation on genomic and protein alterations in 126 triple-negative metaplastic breast cancers.
Advertisement
In this video from the 32nd Annual Miami Breast Cancer Conference, Sherri Z. Millis, PhD, a molecular science liaison at Caris Life Sciences, Phoenix, Ariz., discusses a poster presentation on genomic and protein alterations in 126 triple-negative metaplastic breast cancers.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
2
The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
3
Current Treatment Landscape of HER2-Positive Metastatic Breast Cancer and Phase 3 Trial Overview
4
How Are Key Lymphoma Data From ASCO and EHA 2026 Shaping Treatment?
5













































































